Lymphoseek
Sponsors
Navidea Biopharmaceuticals, Kettering Health Network, Cardinal Health 414, LLC, Eben Rosenthal, Anna Cruceta
Conditions
Anal CancerBreast CancerEndometrial CancerHead CancerHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma (HNSCC)Melanoma
Phase 2
A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
WithdrawnNCT02857608
Start: 2016-09-30End: 2017-08-31Updated: 2017-03-15
Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer
CompletedNCT03405142
Start: 2019-08-01End: 2021-04-27Updated: 2022-11-10
Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
TerminatedNCT04511026
Start: 2021-01-20End: 2021-06-10Updated: 2023-10-11
Phase 3
Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
CompletedNCT00671918
Start: 2008-04-30End: 2009-07-31Updated: 2013-06-17
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
TerminatedNCT00911326
Start: 2009-05-31End: 2013-08-31Updated: 2014-08-08
Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes
CompletedNCT01106040
Start: 2010-06-30End: 2011-04-30Updated: 2013-06-17
Phase 4
Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer
CompletedNCT02287675
Start: 2015-01-19End: 2017-08-31Updated: 2020-07-28
Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer
NCT04261179
Start: 2020-03-31End: 2021-08-31Target: 30Updated: 2020-02-20